...
机译:肿瘤浸润的CD39(+)CD8(+)T细胞确定透明细胞肾细胞癌患者的预后和免疫逃逸不良
Fudan Univ Zhongshan Hosp Dept Urol Shanghai 200032 Peoples R China;
Fudan Univ Zhongshan Hosp Dept Urol Shanghai 200032 Peoples R China;
Fudan Univ Zhongshan Hosp Dept Urol Shanghai 200032 Peoples R China;
Fudan Univ Zhongshan Hosp Dept Urol Shanghai 200032 Peoples R China;
Fudan Univ Sch Basic Med Sci Dept Immunol Shanghai Peoples R China;
Fudan Univ Sch Basic Med Sci Dept Immunol Shanghai Peoples R China;
Fudan Univ Sch Basic Med Sci Dept Biochem &
Mol Biol Shanghai 200032 Peoples R China;
Fudan Univ Sch Basic Med Sci Dept Biochem &
Mol Biol Shanghai 200032 Peoples R China;
Fudan Univ Zhongshan Hosp Dept Urol Shanghai 200032 Peoples R China;
Fudan Univ Shanghai Canc Ctr Dept Urol Shanghai Peoples R China;
Fudan Univ Zhongshan Hosp Dept Urol Shanghai 200032 Peoples R China;
Shanghai Jiao Tong Univ Sch Med Shanghai Peoples Hosp 9 Dept Urol Shanghai Peoples R China;
Fudan Univ Shanghai Canc Ctr Dept Urol Shanghai Peoples R China;
Shanghai Jiao Tong Univ Sch Med Ruijin Hosp Dept Urol Shanghai Peoples R China;
Fudan Univ Zhongshan Hosp Dept Pathol Shanghai Peoples R China;
Fudan Univ Shanghai Canc Ctr Dept Pathol Shanghai Peoples R China;
Fudan Univ Sch Basic Med Sci Dept Immunol Shanghai Peoples R China;
Fudan Univ Shanghai Canc Ctr Dept Urol Shanghai Peoples R China;
Fudan Univ Zhongshan Hosp Dept Urol Shanghai 200032 Peoples R China;
Fudan Univ Zhongshan Hosp Dept Urol Shanghai 200032 Peoples R China;
Fudan Univ Sch Basic Med Sci Dept Biochem &
Mol Biol Shanghai 200032 Peoples R China;
Clear cell renal cell carcinoma; CD39; CD8(+) T cell; Prognosis; Tyrosine kinase inhibitors;
机译:Pak1表达决定了转移性肾细胞癌患者的预后和免疫逃避差
机译:肿瘤内TIGIT CD8 T细胞浸润决定了肌肉侵袭性膀胱癌患者的预后和免疫逃避差
机译:CD39的高表达与透明细胞肾细胞癌中的预后和免疫浸润差有关
机译:从透明细胞肾细胞癌无脂肪鉴别血管性脂肪异常的有效放射学模型。
机译:默克尔细胞多瘤病毒特异的T细胞反应,免疫逃逸机制和免疫疗法在默克尔细胞癌中的作用
机译:CD39的高表达与透明细胞肾细胞癌中的预后和免疫浸润差有关
机译:> CD39的高表达与透明细胞肾细胞癌中的预后和免疫浸润差, p>
机译:烟草烟雾(Ts)对透明细胞肾癌细胞(ccRCC)生长的影响。